Search for: "Capital Pharmaceutical, LLC" Results 41 - 60 of 197
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Dec 2019, 2:19 am by Peter Mahler
It can and was in this case in which the Delaware Chancery Court ordered dissolution of a start-up pharmaceutical company. [read post]
16 Oct 2020, 7:10 am by Renae Lloyd
The company filed a form D in 2020 to raise capital from investors, according to filings with the SEC. [read post]
6 Mar 2018, 5:52 am by Geoff Cockrell
Experts included Fritz Buerger, Investment Banking, William Blair; Christian Pesci, Director, Cain Brothers & Company, LLC; Taylor Phelps, Sr. [read post]
2 Oct 2020, 12:08 pm by Renae Lloyd
The company filed a form D in 2014 to raise capital from investors, according to filings with the SEC. [read post]
2 Oct 2020, 8:40 am by Renae Lloyd
The company filed a form D in 2014 to raise capital from investors, according to filings with the SEC. [read post]
2 Oct 2020, 10:15 am by Renae Lloyd
The company filed a form D in 2014 to raise capital from investors, according to filings with the SEC. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
Beach, No. 15-1089 (written description requirement for new drug treatments) Retirement Capital Access Management Company, LLC v. [read post]
27 Sep 2019, 10:10 am by luiza
While private equity firms bring significant capital resources to healthcare entities, they may lack practical subject matter expertise in the healthcare industry and healthcare compliance, including Anti-Kickback Statute and Stark Law issues. [read post]
8 May 2020, 6:48 am by Silver Law Group
As part of the fraud, the SEC explained that Brickner, a 48-year-old Central Florida resident, operated FirstCanna Pharmaceuticals LLC, FirstCanna Financial LLC, FirstCanna Insurance LLC, and High Country Healing Co. [read post]
11 Jun 2019, 5:12 am by Amber Walsh
The panel of experts included Ben Daverman, Managing Director, GTCR, LLC, Brad Hively, Principal/Operating Partner, RLH Equity, Barrett Polan, Investment Analysis, Hayfin Capital Management LLP, and Phil Smith, Managing Director, Duff & Phelps. [read post]
20 Nov 2011, 6:59 am by Editors
., New York, NYCorporate Affairs Staff Counsel – Chrysler LLC, Aubrun Hills, MICorporate Counsel – Clean Energy Fuels Corp., Seal Beach, CADirector of Compliance – Pharmaceutical – Global Specialty Pharmaceutical Company, Tri-State AreaSenior Counsel or Assistant General Counsel – Global Pharmaceutical Industry Company, Tri-State AreaAssistant General Counsel – Confidential, New York, NYInvestment Management, Associate Counsel… [read post]
5 Sep 2011, 11:49 pm by Editors
– Confidential, Western USIn House Associate Corporate Counsel – Sony Ericsson, Atlanta, GAGeneral Counsel – Fashion Institute of Technology, New York, NYAssistant General Counsel – Rainforest Alliance, New York, NYEmployment and HR Compliance Attorney – Edge Consulting, Milwaukee, WIAssistant General Labor & Employment Counsel – PSEG, Newark, NJ (NYC tri-state area)Corporate Counsel – Ask Partner Network, Oakland, CAGeneral Counsel –… [read post]
1 Jun 2008, 5:08 pm
  Only those with appropriate security clearance (or at least a secret decoder ring) will be able to read the opinion.JDH Capital, LLC v. [read post]
8 Jun 2015, 10:07 am by Dennis Crouch
By Richard Baker, President of New England Intellectual Property, LLC The American Invents Act, passed into law in 2011, is one of the biggest changes to US patent laws in the past fifty years. [read post]
20 Jan 2016, 8:00 am by Dennis Crouch
Eligibility Challenges: Retirement Capital Access Management Company, LLC v. [read post]
“Specialty drugs” are a fast growing sector of the pharmaceutical industry and are predicated to represent 50 percent of drug expenditures in the United States by 2020.[1] Specialty drugs are typically dispensed by specialty pharmacies. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Beach, No. 15-1089 (written description requirement for new drug treatments) Retirement Capital Access Management Company, LLC v. [read post]
18 Mar 2019, 6:47 am by Staff Attorney
” The SEC’s allegations focus on stocks including BioZone Pharmaceuticals (now Cocrystal Pharma) (COCP), MGT Capital (OTC: MGTI), and MabVax Therapeutics (OTC: MBVX). [read post]